{"url_path":"/sec/maze/8-k/2026-05-12/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1842295/0001193125-26-219398-index.html","accession_number":"0001193125-26-219398","cik":"0001842295","ticker":"MAZE","issuer_name":"Maze Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1842295/0001193125-26-219398-index.html","primary_entity_key":"0001842295","primary_entity_name":"Maze Therapeutics, Inc."},"word_count":77,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n \n\nExhibit\n\nNumber\n\nDescription\n\n99.1\n\n[Press Release announcing financial results, dated May 12, 2026.](maze-ex99_1.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDate:\n\nMay 12, 2026\n\nBy:\n\n/s/ Courtney Phillips\n\n \n\n \n\n \n\nCourtney Phillips\n\nGeneral Counsel and Corporate Secretary"}